Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma.
Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Dae-Won
DW
Lee
Hyun
H
Chang
Yu-Jung
YJ
Kim
Kwhan-Mien
KM
Kim
Hee-Jin
HJ
Lee
Jong-Seok
JS
Lee
D000328:Adult; D018207:Angiomyolipoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001707:Biopsy, Needle; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D009392:Nephrectomy; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib